Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Metallomics ; 6(7): 1296-300, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24889871

ABSTRACT

Zinc is an essential trace element involved in the correct packing and storage of insulin. Total zinc content in the pancreatic ß-cells is among the highest in the body and changes in the Zn(2+) levels have been found to be associated with diabetes. The most common form of the Zn-insulin complex is a hexamer containing two zinc ions. However, zinc can also form other complexes with insulin, whereas dissociation constants of these complexes are not known. We have determined that the dissociation constant value of the monomeric 1 : 1 Zn-insulin complex is equal to 0.40 µM. The apparent binding affinity decreases drastically at higher insulin concentrations where the peptide forms dimers. Cu(2+) ions also bind to monomeric insulin, whereas the apparent Cu(2+)-binding affinity depends on HEPES concentration. The conditional dissociation constant of the Cu(2+)-insulin complex is equal to 0.025 µM. The analysis demonstrates that insulin cannot form complexes with zinc ions in circulation due to the low concentration of free Zn(2+) in this environment.


Subject(s)
Copper/chemistry , Insulin/metabolism , Zinc/chemistry , Cations, Divalent/chemistry , HEPES/administration & dosage , Insulin/chemistry , Kinetics , Protein Binding/drug effects , Protein Structure, Quaternary , Spectrometry, Fluorescence
2.
Poult Sci ; 92(4): 874-81, 2013 Apr.
Article in English | MEDLINE | ID: mdl-23472009

ABSTRACT

A hypothesis was tested that the in ovo injection of biological buffers may reinforce the buffering capacity of albumen, thereby withstanding the increase in albumen pH during storage and improving hatchability and chick quality in long-term stored eggs. Hatching eggs (n = 2,420) were randomly assigned to 11 treatment groups (4 replicates of 55 eggs each) and injected (d 1) with distilled water, 25 or 50 mM HEPES (H25 and H50), Bicine (B25 and B50), Tris (T25 and T50), and Bis-Tris-propane (BTP25 and BTP50) solutions or were not injected (intact: control; or pricked with a needle: N). The eggs were then stored for 14 d during which the egg internal characteristics were evaluated at 1, 2, 3, 4, 5, 8, and 13 d of storage (n = 924 in total) and the remaining eggs (n = 1,496) were incubated. A decrease in albumen pH was found for H25, H50, B50, and BTP25 groups from 2 through 5 d postinjection. Eggs receiving H25, H50, and B50 recorded a higher albumen index (at 13 d of storage) and Haugh unit (between 8 and 13 d of storage) compared with the control. Interestingly, the hatchability of fertile eggs was influenced by the treatment effect (P = 0.0001) where the eggs receiving H25 (88.3%), H50 (88.9%), B50 (88.4%), and BTP25 (87.6%) recorded higher values than that of control (82.1%), associated with a decreased early embryonic mortality rate (P < 0.0001). In ovo injection of Tris buffer, however, profoundly decreased the hatchability (47.2 and 29.0% for T25 and T50, respectively) and percentage of first-grade chicks (67.5 and 63.6% for T25 and T50, respectively) compared with the control (90.1%). In conclusion, prestorage in ovo injection of H25, H50, B50, and BTP25 improved hatchability in long-term stored eggs in which a decreased albumen pH during the d 2 through 5 of storage period might be involved.


Subject(s)
Animal Husbandry/methods , Chickens/physiology , Glycine/analogs & derivatives , HEPES/administration & dosage , Ovum/physiology , Tromethamine/administration & dosage , Animals , Buffers , Chick Embryo/physiology , Glycine/administration & dosage , Hydrogen-Ion Concentration , Random Allocation , Tromethamine/analogs & derivatives
3.
J Nanobiotechnology ; 9: 13, 2011 Apr 08.
Article in English | MEDLINE | ID: mdl-21477294

ABSTRACT

BACKGROUND: The use of silica coated magnetic nanoparticles as contrast agents has resulted in the production of highly stable, non-toxic solutions that can be manipulated via an external magnetic field. As a result, the interaction of these nanocomposites with cells is of vital importance in understanding their behaviour and biocompatibility. Here we report the preparation, characterisation and potential application of new "two-in-one" magnetic fluorescent nanocomposites composed of silica-coated magnetite nanoparticles covalently linked to a porphyrin moiety. METHOD: The experiments were performed by administering porphyrin functionalised silica-coated magnetite nanoparticles to THP-1 cells, a human acute monocytic leukaemia cell line. Cells were cultured in RPMI 1640 medium with 25 mM HEPES supplemented with heat-inactivated foetal bovine serum (FBS). RESULTS: We have synthesised, characterised and analysed in vitro, a new multimodal (magnetic and fluorescent) porphyrin magnetic nanoparticle composite (PMNC). Initial co-incubation experiments performed with THP-1 macrophage cells were promising; however the PMNC photobleached under confocal microscopy study. ß-mercaptoethanol (ß-ME) was employed to counteract this problem and resulted not only in enhanced fluorescence emission, but also allowed for elongated imaging and increased exposure times of the PMNC in a cellular environment. CONCLUSION: Our experiments have demonstrated that ß-ME visibly enhances the emission intensity. No deleterious effects to the cells were witnessed upon co-incubation with ß-ME alone and no increases in background fluorescence were recorded. These results should present an interest for further development of in vitro biological imaging techniques.


Subject(s)
Magnetite Nanoparticles/chemistry , Nanoconjugates/chemistry , Porphyrins/chemical synthesis , Cell Line, Tumor , Diagnostic Imaging/methods , HEPES/administration & dosage , Humans , Macrophages/cytology , Macrophages/metabolism , Macrophages/ultrastructure , Magnetite Nanoparticles/ultrastructure , Mercaptoethanol/administration & dosage , Microscopy, Confocal/methods , Nanoconjugates/ultrastructure , Photobleaching , Porphyrins/metabolism , Staining and Labeling/methods
4.
Mol Immunol ; 47(9): 1839-47, 2010 May.
Article in English | MEDLINE | ID: mdl-20347151

ABSTRACT

Expression of CD137, a member of the tumor necrosis factor receptor family, is inducible on vascular endothelial cells by proinflammatory stimuli. Its ligand is expressed as a transmembrane protein on the surface of monocytes, and transmits activating signals into monocytes (reverse signaling) inducing monocyte migration. These findings led to the hypothesis that CD137 expression on activated endothelial cells facilitates recruitment of monocytes into inflammatory tissues including atherosclerotic lesions. Data from this study demonstrate that CD137 expression is inducible on endothelial cells by TNF stimulation. Recombinant CD137 protein and CD137 expressed on activated endothelial cells enhance ICAM-1-mediated adhesion of monocytes under defined flow conditions in vitro. CD137 seems not to play a role in tethering of monocytes since this activity is completely E-selectin-dependent. In addition, LFA-1 affinity and clustering on monocytic cells is enhanced by CD137. In summary, CD137 expression is induced on vascular endothelial cells by proinflammatory mediators and strengthens ICAM-1 and LFA-1-mediated adhesion of monocytes. These data support a role for CD137 in the recruitment of monocytes to inflammatory tissues.


Subject(s)
E-Selectin/metabolism , Intercellular Adhesion Molecule-1/metabolism , Monocytes/metabolism , Tumor Necrosis Factor Receptor Superfamily, Member 9/metabolism , Calcium Chloride/administration & dosage , Cell Adhesion , Cell Communication , Cell Line , Cells, Cultured , Endothelial Cells/cytology , Endothelial Cells/drug effects , Endothelial Cells/metabolism , Flow Cytometry , Gene Expression/drug effects , HEPES/administration & dosage , Humans , Immunohistochemistry , Monocytes/cytology , Monocytes/drug effects , Protein Binding , Reverse Transcriptase Polymerase Chain Reaction , Rheology , Solutions/administration & dosage , Stress, Mechanical , Tumor Necrosis Factor Receptor Superfamily, Member 9/genetics , Tumor Necrosis Factor-alpha/pharmacology , U937 Cells
7.
Fertil Steril ; 85(5): 1415-9, 2006 May.
Article in English | MEDLINE | ID: mdl-16600227

ABSTRACT

OBJECTIVE: This study was conducted to determine whether N-hydroxyethylpiperazine-N-ethanesulfonate (HEPES)-buffered medium used for the microinjection of sperm into oocytes may be detrimental for the embryo. DESIGN: Controlled randomized study. SETTING: Private IVF center. PATIENT(S): Women (n = 708) undergoing ICSI. INTERVENTION(S): The women were randomized into two study groups: 2,204 oocytes from 357 women were treated using a medium buffered with bicarbonate without HEPES during the ICSI procedure, and 2,168 oocytes from 351 women were treated using a medium buffered with HEPES during the ICSI procedure. MAIN OUTCOME MEASURE(S): Fertilization rate, degeneration rate, triploid rate, cleavage rate, embryo quality, pregnancy rate, implantation rate, and abortion rate. RESULT(S): Oocytes treated with a HEPES-buffered medium showed a statistically significant higher rate of triploid and degenerated oocytes after fertilization with ICSI compared with oocytes treated with a medium without HEPES. The embryos obtained from oocytes microinjected with a HEPES-buffered medium showed a statistically significant higher rate of highly fragmented embryos compared with the controls. Pregnancy rate and implantation rate were statistically significantly lower in the patient group with oocytes treated with the HEPES-buffered medium. The other parameters evaluated did not show any statistically significant differences. CONCLUSION(S): Our study showed that the use of media buffered with HEPES, during the microinjection of sperm into the oocytes, is detrimental for IVF outcome and should be avoided.


Subject(s)
HEPES/administration & dosage , Infertility, Female/epidemiology , Infertility, Female/therapy , Sperm Injections, Intracytoplasmic/statistics & numerical data , Adult , Buffers , Culture Media/chemistry , Female , Fertilization in Vitro/statistics & numerical data , HEPES/chemistry , Humans , Outcome Assessment, Health Care , Pregnancy , Pregnancy Outcome , Treatment Failure , Treatment Outcome
8.
Cryobiology ; 46(2): 121-34, 2003 Apr.
Article in English | MEDLINE | ID: mdl-12686202

ABSTRACT

Sugars such as trehalose are effectively used by various organisms as protective agents to undergo anhydrobiosis and cryobiosis. The objective of this study was first to establish a method for quantitative delivery of trehalose as a model sugar into oocytes, and then to evaluate its effect on development of mouse zygotes. To this end, a quantitative microinjection technique was developed using volumetric response of microdroplets suspended in dimethylpolysilaxene. To verify accuracy of this technique, both microdroplets and oocytes were microinjected with fluorophore-labeled dextran. Thereafter, injection volumes were calculated from fluorescence intensity, and volumetric responses of both microdroplets and oocytes. Comparison of calculated injection volumes revealed that this technique reflects microinjection into oocytes with pL-accuracy. The next series of experiments focused on toxicity of injection buffers (i.e., 10mM Tris and 15mM Hepes) and trehalose. Microinjection of Hepes and Tris buffer in the presence of 0.1M trehalose resulted in blastocyst rates of 86 and 72%, respectively, without a significant difference when compared to controls (86%). In subsequent experiments, Hepes was used as the injection buffer, and embryonic development of zygotes was studied as a function of intracellular trehalose concentrations. Microinjection of trehalose up to 0.15M resulted in development to blastocyst stage similar to controls (85 and 87%, respectively) while the blastocyst rate was significantly decreased (43%) in the presence of 0.20M intracellular trehalose. When transferred to foster mothers, trehalose-injected zygotes (0.1M) implanted and developed to day 16 fetuses similar to controls, healthy pups were born. The findings of this study suggest that trehalose at effective intracellular concentrations does not impair development of mouse zygotes.


Subject(s)
Embryonic and Fetal Development/drug effects , Microinjections/methods , Oocytes/drug effects , Trehalose/pharmacology , Zygote/drug effects , Animals , Blastocyst/drug effects , Cryopreservation/methods , Cryoprotective Agents/administration & dosage , Cryoprotective Agents/pharmacology , Dose-Response Relationship, Drug , Embryo Transfer , Female , HEPES/administration & dosage , HEPES/toxicity , Male , Mice , Pregnancy , Trehalose/administration & dosage , Trehalose/adverse effects , Tromethamine/administration & dosage , Tromethamine/toxicity
9.
Caries Res ; 32(3): 200-3, 1998.
Article in English | MEDLINE | ID: mdl-9577985

ABSTRACT

The fluoride concentration in cows' milk has been reported to vary with the fluoride levels in drinking water but it seldom exceeds 0.5 microg/ml. This raised a question as to whether any caries-protective effect could be attributed to the intrinsic fluoride of milk. Two samples of cows' milk with intrinsic fluoride concentrations of 0.03 and 0.3 microg/ml, respectively, were assessed for their protective effect on enamel in an in vitro demineralization model at relatively severe and mild acidic challenges (pH 4.6 and 5.0, respectively). Polished enamel discs were incubated individually in 5.0 ml of demineralization solution for 20 h per day alternated with 1-hour incubations in 1.0 ml of milk or control buffers: group 1, demineralization solution only (negative control); group 2, milk with 0.03 microg/ml fluoride; group 3, milk with 0.03 microg/ml fluoride; supplemented with NaF to 0.3 microg/ml fluoride; group 4, milk with 0.3 microg/ml fluoride; group 5, 0.3 microg/ml fluoride in 20 mM HEPES, pH 6.7; group 6, milk with 0.03 microg/ml fluoride supplemented with NaF to 5.0 microg/ml fluoride (positive control). The solutions were renewed each day and the calcium concentration in the demineralization solutions was followed during 4 days. The results showed that the protective effect of intrinsic milk fluoride on enamel is limited by the severity of the acidic challenge: There was a significant inhibition of the demineralization in groups 3-6 compared to groups 1 and 2, but only at pH 5.0 (p<0.0001) and not at pH 4.6 (p = 0.2). The organic components of milk had limited protection against demineralization because milk and HEPES with the same fluoride concentration gave similar results. The 36% reduction in calcium loss at pH 5.0 by treatment with milk with only 0.3 microg/ml fluoride is an indication that intrinsic milk fluoride has some caries-protective properties.


Subject(s)
Cariostatic Agents/pharmacology , Dental Enamel/drug effects , Fluorides/pharmacology , Milk , Tooth Demineralization/prevention & control , Acetates/pharmacology , Analysis of Variance , Animals , Buffers , Calcium/analysis , Calcium Chloride/pharmacology , Cariostatic Agents/administration & dosage , Cariostatic Agents/analysis , Cattle , Fluorides/administration & dosage , Fluorides/analysis , Food, Fortified , HEPES/administration & dosage , HEPES/pharmacology , Hydrogen-Ion Concentration , Hydroxides/pharmacology , Milk/chemistry , Phosphates/pharmacology , Potassium Compounds/pharmacology , Sodium Fluoride/administration & dosage , Sodium Fluoride/pharmacology , Sodium Nitrite/pharmacology , Tooth Demineralization/physiopathology
10.
Free Radic Biol Med ; 24(4): 522-8, 1998 Mar 01.
Article in English | MEDLINE | ID: mdl-9559863

ABSTRACT

The cytotoxicity of the superoxide anion radical- and nitric oxide-releasing compound SIN-1 to L929 cells was studied in Krebs-Henseleit buffer. pH 7.4, in the presence and absence of Hepes. SIN-1 cytotoxicity was significantly higher in the presence of Hepes than in the absence of Hepes. The available amount of peroxynitrite formed from SIN-1, however, was significantly decreased by Hepes as indicated by decreased oxidation of dihydrorhodamine 123. On the other hand, Hepes largely increased the formation of H2O2 from SIN-1. Catalase protected the L929 cells from SIN-1 cytotoxicity in the buffer with Hepes. In the buffer without Hepes catalase did not have any protective effect. In contrast, tyrosine and tryptophan provided significant protection against SIN-1 cytotoxicity independent of the presence of Hepes. These results demonstrate that the immediate toxic agent formed from SIN-1 decisively depends on the presence of Hepes. In its absence cytotoxicity is most likely mediated by peroxynitrite while in the presence of Hepes, cytotoxicity is conveyed by co-operative action of hydrogen peroxide and reactive nitrogen species.


Subject(s)
Cell Death , HEPES/pharmacology , Hydrogen Peroxide/pharmacology , Molsidomine/analogs & derivatives , Nitrates/pharmacology , Animals , Buffers , Catalase/pharmacology , Cell Line , Fibroblasts , HEPES/administration & dosage , Hydrogen Peroxide/metabolism , Kinetics , L-Lactate Dehydrogenase/metabolism , Mice , Molsidomine/metabolism , Molsidomine/toxicity , Nitrates/metabolism
11.
J Pharm Pharmacol ; 46(9): 745-50, 1994 Sep.
Article in English | MEDLINE | ID: mdl-7837044

ABSTRACT

The effect of in-vivo administration of N-2-hydroxyethylpiperazine-N'-2- ethane sulphonic acid (HEPES) and taurine on rat paw oedema and reactive oxidant production was examined. Carrageenan-induced paw oedema was attenuated following intraperitoneal injection of HEPES. Chemiluminescence production by isolated peripheral blood mononuclear cells (PBMC) was reduced in HEPES-treated rats. Taurine-treated rats did not exhibit attenuation of paw oedema using subcutaneous or intraperitoneal administration but intracerebroventricular administration produced a significant reduction at a dosage of 4.0 mumol. No reduction in chemiluminescence production was observed by PBMC using subcutaneous or intraperitoneal administration of taurine, but intracerebroventricular administration produced a significant reduction at a dosage of both 0.4 and 4.0 mumol. Intravenous injection of [14C]HEPES or [3H]taurine demonstrated rapid clearance with a significantly longer half-life of HEPES compared with taurine. These results support previous reports of anti-inflammatory activity of taurine when administered centrally. The lack of anti-inflammatory effect when taurine was administered subcutaneously or intraperitoneally may be a consequence of rapid distribution or clearance. The greater anti-inflammatory effects of HEPES compared with taurine may be due to its slower distribution or clearance in-vivo.


Subject(s)
HEPES/pharmacology , Inflammation/drug therapy , Taurine/pharmacology , Animals , Carrageenan , Drug Administration Routes , Edema/chemically induced , Edema/prevention & control , Female , HEPES/administration & dosage , HEPES/pharmacokinetics , Half-Life , Inflammation/chemically induced , Injections, Intraperitoneal , Injections, Intravenous , Injections, Intraventricular , Leukocytes, Mononuclear/drug effects , Luminescent Measurements , Male , Rats , Rats, Wistar , Reactive Oxygen Species/metabolism , Taurine/administration & dosage , Taurine/pharmacokinetics , Tissue Distribution
SELECTION OF CITATIONS
SEARCH DETAIL
...